Category : Search result: Mayne Pharma

Mayne Pharma Plunges as US Deal Controversy Continues

Australian pharmaceutical giant Mayne Pharma faces investor backlash as its controversial US licensing agreement continues to dominate trading, creating clear winners and losers on the ASX.